Perform immunoblotting using microsomal protein extracts from wild-type and pen3 knockout mutants (e.g., pen3-4 or pen3-7). Null mutants show no detectable PEN3 signal, while hypomorphic alleles (e.g., pen3-1) exhibit reduced protein levels .
Include loading controls (e.g., MPK6) and total protein stains (Ponceau S) to confirm equal loading .
Validate using PEN3-GFP fusion lines, where the antibody should detect both native PEN3 (~165 kDa) and PEN3-GFP (~192 kDa) .
Western blotting: Analyze PEN3 expression kinetics during Botrytis cinerea infection, which induces transcriptional upregulation via MPK3/MPK6-WRKY33 signaling .
Localization studies: PEN3 localizes to the plasma membrane; use subcellular fractionation (e.g., microsomal membrane isolation) to confirm .
Functional assays: Compare camalexin secretion in pen3 single vs. pen3 pdr12 double mutants to assess redundancy .
Experimental design: Use pathogen-specific assays:
Key controls: Include pen3 alleles with stable protein levels (e.g., pen3-5) to distinguish transport activity from protein stability effects .
Genetic analysis: Generate double mutants (e.g., pen3-3 pdr12-2) and quantify:
Transcript profiling: Monitor PEN3 and PDR12 induction post-infection using qRT-PCR or promoter-GUS fusions .
Sample preparation: Avoid boiling samples; denature at 65°C for 5–10 minutes to preserve PEN3 epitopes .
Technical replicates: Include multiple biological replicates to account for tissue-specific expression variations (e.g., higher PEN3 levels in infected leaves) .
Antibody lot validation: Compare signals across independent PEN3 antibodies (e.g., Agrisera AS22 4846 vs. CUSABIO variants) .
Metabolite profiling: Combine pen3 mutants with cyp79b2 cyp79b3 (defective in indole glucosinolate biosynthesis) to isolate PEN3-specific substrates .
Radiolabeled assays: Use ¹⁴C-labeled camalexin to directly measure transport activity in membrane vesicles .
Genetic suppressors: Screen for suppressors of pen3 hypersensitivity to camalexin to identify compensatory transporters .
Membrane enrichment: Isolate microsomal fractions via differential centrifugation .
Antibody dilution optimization: Test concentrations between 1:1,000 and 1:20,000; Agrisera’s antibody works at 1:10,000 .
Blocking buffers: Use 5% non-fat milk in PBS-T to reduce background noise .
Mutation type: T-DNA insertions (pen3-4, pen3-7) abolish protein, while missense mutations (e.g., pen3-1 L704F) reduce stability .
Epitope integrity: Antibodies targeting the N-terminus may fail to detect truncated PEN3 variants .